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I N T R O D U C T I O N
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain, hypersensitivity, and changes in bowel activity in the relative absence of inflammation or other structural changes (Camilleri 2005; Gershon and Tack. 2007; Spiller 2007) . Despite continuing investigation, the pathogenic mechanisms of IBS remain unclear (Drossman et al. 1997) .
Several endogenous mediators have been implicated in gastrointestinal hypersensitivity in general and IBS in particular, including serotonin (Gershon and Tack. 2007; Mawe et al. 2006) , proteases (Cenac et al. 2007; Coelho et al. 2002; Kirkup et al. 2003) , and adenosine-5=-triphosphate (ATP). ATP has been of long-term interest as a signaling molecule in the gut (Burnstock 2001 (Burnstock , 2008 . ATP is released from a wide variety of cells (North 2002) , including colonic epithelium in response to colorectal distension (Shinoda et al. 2009; Wynn et al. 2003) . ATP and its metabolites can interact with a large number of ligand-gated ion channels (P2X receptors) and G-protein-coupled receptors of the P2Y family. P2X receptors are expressed on sensory neuron cell bodies in dorsal root ganglia (DRG) (Burnstock 2006) , including visceral sensory DRG neurons (Dang et al. 2008; Wynn et al. 2003) . ATP also contributes to colorectal mechanotransduction by activating pelvic nerve afferents (Wynn et al. 2003) , a role that is enhanced after colon inflammation (Wynn et al. 2004) . It also has been reported that P2X receptor antagonists reverse visceral hypersensitivity, further supporting the contribution of ATP to visceral sensory mechanisms . Finally, ATP is implicated in human colon pathology by increased expression of P2X 3 receptors in inflammatory bowel disease (Yiangou et al. 2001) .
We previously documented that colorectal mechanotransduction and zymosan-produced colon hypersensitivity, which develops and persists in the absence of a neutrophil-based colorectal inflammation, are attenuated and do not develop, respectively, in P2X 3 Ϫ/Ϫ mice (Shinoda et al. 2009 ). These outcomes further support a role for purinergic signaling in colorectal hypersensitivity. In the present study, we examined purinergic responses and P2X receptor expression in colorectal DRG (c-DRG) neurons after intracolonic saline or zymosan treatment (replicating the visceral hypersensitivity in IBS patients), hypothesizing that the robust colon hypersensitivity produced would be associated with increased cell excitability and enhanced purinergic sensitivity.
Probes, Eugene, OR) was injected into one to three sites within the descending colon wall (ϳ1.5 cm from the anal verge) using a 30-gauge needle (ϳ6 l per site). Visible leakage of DiI was removed with a cotton swab. The incision was closed (5-0 polyglactin sutures; Ethicon, Somerville, NJ), and mice were subsequently returned to their home cages until use 14 -21 days later.
Intracolonic treatments
Mice were anesthetized with ketamine/xylazine (87.5/12.5 mg/kg ip) and 0.1 ml of saline or of a suspension of 30 mg/ml zymosan (derived from Saccharomyces cerevisiae; Sigma, St. Louis, MO) in saline was administered transanally via a 22-gauge, 24-mm-long stainless-steel feeding needle. Saline or zymosan was given daily for three consecutive days; lumbosacral (LS) and thoracolumbar (TL) DRG were harvested on day 4. This treatment protocol results in a robust and long-lasting colon hypersensitivity to balloon distension (Shinoda et al. 2009 ). We checked each mouse postmortem for leakage of DiI by examining the colon and surrounding tissues after removal of DRG. No labeling in any tissue other than the colon was noted.
Cell dissociation and culture
The mouse colon is innervated by pelvic and lumbar splanchnic nerves with cell bodies contained in LS and TL DRG, respectively. Because there are significant differences between the LS and TL innervations of pelvic organs (Brierley et al. 2005; Dang et al. 2008; Xu and Gebhart. 2008) , c-DRG neurons from both innervations were studied. Mice were killed via CO 2 inhalation and T 11 --L 1 or L6 -S 2 DRG removed rapidly and incubated at 37°C in 5% CO 2 for 40 min in serum free, advanced Dulbecco's modified eagle medium (DMEM)/F12 containing 1% penicillin/streptomycin (Invitrogen, Carlsbad, CA), collagenase (type 4; 2 mg/ml; Worthington Biochemical, Lakewood, NJ), and trypsin (1 mg/ml; Worthington). After washing three times with advanced DMEM/ F12 containing 10% fetal bovine serum (Sigma; without enzymes), DRG were submerged in DMEM containing 10% fetal bovine serum, 1% penicillin/streptomycin, 625 M L-glucose, 4.5 g/l D-glucose, 110 mg/l sodium pyruvate and triturated gently to encourage cell dissociation. Neurons were plated on poly-D-lysinecoated coverslips (Becton Dickinson Labware, Bedford, MA) and incubated at 37°C in 5% CO 2 . Only c-DRG neurons (i.e., DiIcontaining DRG neurons) were studied. All recordings were performed within 24 h after plating.
Solutions and electrophysiological recordings
Coverslips with cells were transferred to a recording chamber (1 ml) and superfused continuously (2 ml/min) with external solution containing (in mM): 140 NaCl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 HEPES, and 10 glucose. The pH was adjusted to 7.4 with NaOH (305 mosM). Neurons that innervated the colon were identified by DiI content using a rhodamine filter. Fire-polished micropipettes with tip resistances of 2-4 M⍀ were used for current-and voltage-clamp recordings. The uncompensated series resistance was generally Ͻ10 M⍀. The pipette was filled with an internal solution consisting of (in mM): 130 KCl, 0.2 CaCl 2 , 4 NaCl, 10 EGTA, 10 HEPES, 0.5 Na triphosphate, and 2 MgATP. The pH was adjusted to 7.25 using KOH (290 mosM). After establishing the whole cell configuration, the voltage was clamped at Ϫ70 mV using an Axopatch 200B amplifier, digitized at 1 kHz (Digidata 1350), and controlled by Clampex software (pClamp 10.0; all from Axon Instruments, Foster City, CA). Cell capacitance and resting membrane potential (RMP) were obtained from the Axopatch 200B amplifier. Recordings began 3 min after establishing whole cell configuration to ensure stable recording conditions. Only cells that had a RMP more negative than Ϫ40 mV and generated action potentials with a distinct overshoot Ͼ0 mV in response to depolarizing current injections were studied. Spontaneous activity was counted during a 1 min period before electrical or chemical stimulation. A series of 5-ms current pulses in 50-pA increments (1 s apart) was injected to determine action potential (AP) threshold, which was taken as the greatest membrane potential in the absence of an AP; the minimum current required to evoke an AP was considered rheobase. To examine firing patterns in c-DRG neurons, suprathreshold current (2 ϫ rheobase) was injected for 500 ms and the number of APs counted. Drugs were applied using a fast-step SF-77B superfusion system (Warner Instruments, Hamden, CT) with a three-barrel pipette placed in close proximity (100 m) to the cell, allowing complete solution exchange within 25 ms (Dang et al. 2005a ). Purinergic agonists [ATP and ␣,␤-methylene ATP (␣,␤-meATP); Sigma] were applied for 2 s, whereas antagonists were superfused for 30 s before the application of agonists. A washout period of 4 min was allowed between agonist applications. Drugs and chemicals were prepared fresh from stock solutions on the day of the experiment; experiments were performed at room temperature (21-23°C). We used current increases Ͼ20 pA or voltage changes Ͼ4 mV to identify responses to purinergic agonists because these levels exceeded baseline variability by a factor of two. To determine the kinetics of response onset, we measured the time from 10 to 80% of peak amplitude.
To isolate voltage-gated K ϩ (Kv) currents and minimize contamination by Na ϩ and Ca 2ϩ , NaCl was replaced with an equimolar amount of choline chloride, and CdCl 2 (50 M) was included in the external solution (pH was adjusted to 7.4 with Tris-base). Cells were held at Ϫ70 mV and subjected to either a Ϫ100 or Ϫ30 mV prepulse potential for 400 ms before outward currents were elicited by stepping the membrane potential from Ϫ60 to 40 mV for 400 ms in 10 mV increments. Inactivating Kv currents were isolated by subtracting the outward currents after Ϫ30 mV prepulse from those after Ϫ100 mV. The Ϫ30 mV prepulse for evoking the noninactivating currents was chosen based on the steady-state inactivation/availability curve of K ϩ currents in a pilot study. Series resistance was compensated by Ͼ80%, and leak currents were subtracted using the on-line P/4 protocol. Data were sampled at 10 kHz and low-pass filtered at 5 kHz.
Immunohistochemistry
Mice were anesthetized with ketamine/xylazine as in the preceding text and transcardially perfused with saline followed by a cold fixative containing 4% paraformaldehyde in 0.2% picric acid and 0.1 M phosphate buffer (pH 7.4). T 11 -L 1 or L 6 -S 2 DRG were removed rapidly and immersed in the same fixative for 4 h at 4°C. Postfixed DRG were cryoprotected for 12 h in 0.1 M phosphate buffered saline (PBS) containing 20% sucrose, then embedded in Tissue-Tek (Sakura Finetechnical, Tokyo, Japan) at Ϫ20°C and cut on a cryostat (10 m). DRG sections were reacted with rabbit anti-P2X 3 polyclonal antiserum (1:1000; Neuromics, Northfield, MN) overnight at 4°C. After rinsing with 0.01 M PBS, all samples were reacted with AlexaFluor488-conjugated goat anti-rabbit IgG (Invitrogen) at a dilution of 1:200 in 0.01 M PBS for 2 h at room temperature. After rinsing with 0.01 M PBS, sections were coverslipped in mounting medium (Dako, Carpinteria, CA) and examined under a fluorescence microscope. Using appropriate filters, double (DiI and AlexaFluor488)-labeled cells were identified and analyzed using ImageJ software (National Institutes of Health). Cells twofold or more intense than average background were considered positive for P2X 3 immunoreactivity. No specific labeling was observed in the absence of primary antibody or in DRG from P2X 3 Ϫ/Ϫ mice. The percentage of P2X 3 immunoreactive, DiI-labeled c-DRG neurons was calculated based on neuron counts in five randomly chosen sections separated by 100 m to avoid double counting of cells. Histological analysis was performed blind with respect to treatment to colon.
Single-cell reverse transcription polymerase chain reaction (RT-PCR)
DiI-labeled c-DRG neurons (dissociated and cultured as in the preceding text) were collected with large-bore (ϳ50 m) glass pipettes and expelled into microcentrifuge tubes containing reverse- Passive and active properties of c-DRG neurons from saline-and zymosantreated mice examined in current-clamp mode. Examples illustrate that neither LS (A, left ) nor TL (F, left) neurons were spontaneously active in control mice, but ϳ1/6 of LS neurons from zymosan-treated mice exhibited spontaneous activity (A, right). The excitability of LS and TL neurons as well as the number of TL neurons in which action potentials were produced by ATP (e.g., I, right; see also transcriptase (RT) mix (Nealen et al. 2003) . Cell lysis and RT reactions consisted of incubation at 65°C for 1.5 min, at room temperature for 2 min, at 37°C for 20 min after administrating 20 U SuperScript II (Invitrogen), and at 65°C for 10 min. For each experiment, negative controls were performed by omitting reverse transcriptase or using a cell-free bath aspirate as template. The first-strand complementary deoxyribonucleic acid (cDNA) from a c-DRG neuron was used as template in a polymerase chain reaction (PCR) containing 1xGoTaq reaction buffer (Promega, Madison, WI), 10 M outer primers, 0.2 mM dNTPs, and 0.2 l GoTaq DNA polymerase (Promega); primer sequences are listed in Table 1A . Reactions consisted of initialization at 95°C for 10 min, 35 cycles at 94°C/30 s, 52°C/30 s and 72°C/30 s before a final extension step at 72°C for 10 min. Each initial PCR product served as template in a subsequent PCR reaction using a nested primer pair. Each PCR product in a subsequent PCR reaction was electrophoresed on 2% agarose-ethidium bromide gels and photographed. Only neurons producing detectable amplification of a housekeeping gene (GAPDH) were analyzed further.
Data analysis
Data are presented as means Ϯ SE. The software packages pClamp 10.0 (Axon Instruments) and Prism 4 (Graph Pad, San Diego, CA) were used for data analysis. Dose-response curves were fit to sigmoidal functions using the following equation:
], where X is the logarithm of agonist concentration and Y is the response and starts at 0 and ends at A with a sigmoidal shape. B is the Hill slope. Desensitization kinetics were fitted with a standard exponential equation:
, where Y is the current amplitude at time t, K 0 is the amplitude of the sustained component, and is the time constant. K 0 and K 1 represent the contribution to current amplitude from the fast and slow components of the current, respectively. For dichotomous variables, 2 or unconditional exact tests were used. Statistical analyses were performed using Student's t-test and one-or two-way (repeatedmeasures) ANOVA where appropriate. Results were considered statistically significant when P Յ 0.05.
R E S U L T S

Cell size
In previous studies, rat LS and TL colon (Gold and Traub 2004) and urinary bladder (Dang et al. 2005a; Yoshimura and De Groat. 1999) neurons were reported to differ in size and to increase after organ inflammation (Dang et al. 2008 ). Mean whole cell capacitances (as an index of cell size) did not significantly differ between mouse LS (33.5 Ϯ 1.3 pF) and TL (32.96 Ϯ 1.7 pF) c-DRG neurons and were not changed after zymosan treatment (Fig. 1) .
c-DRG neuron excitability
ACTIVE AND PASSIVE MEMBRANE PROPERTIES. Zymosan treatment was associated with a significantly depolarized RMP and enhanced membrane excitability in both LS and TL c-DRG neurons (Fig. 2) . No c-DRG neurons from saline-treated mice exhibited spontaneous activity (LS: 0/35; TL: 0/37), but a significant proportion of LS neurons (6/37, 16%; unconditional exact test, P Ͻ 0.05) from zymosan-treated mice were spontaneously active (Table 2) . Zymosan treatment did not affect action potential (AP) threshold, rheobase, number of APs evoked by suprathreshold current injection (2 X rheobase) or input resistance.
Effect of purinergic agonists
In current clamp mode, ATP (30 M) depolarized one-half of LS (20/38, 53%) and TL (17/34, 50%) c-DRG neurons from saline-treated mice, triggering APs in 6% of LS and 3% of TL neurons (Fig. 2, D and I ; Table 2 ). Zymosan treatment did not change the magnitude of depolarization produced by ATP in either LS (21/31; 68%) or TL (15/20; 75%) c-DRG neurons compared with control (Table 2) . Zymosan treatment did, however, significantly increase the proportion of TL c-DRG neurons in which APs were triggered by ATP (4/20, 20% vs. 1/34, 3% in control; unconditional exact test, P Ͻ 0.05).
␣,␤-meATP, a selective homomeric P2X 3 and heteromeric P2X 2/3 receptor agonist (North 2002), was applied to the same neurons previously challenged with ATP. The proportion of TL c-DRG neurons from saline-treated mice depolarized by ␣,␤-meATP (30 M) was significantly greater than the proportion of LS neurons (LS: 8/31, 26%. TL: 16/32, 50%.
2 test, P Ͻ 0.05); ␣,␤-meATP did not trigger APs in either LS or TL c-DRG neurons (Fig. 2 , E and J, Table 2 ). In zymosan-treated mice, the proportion of LS c-DRG neurons depolarized by ␣,␤-meATP was significantly increased (15/25, 60% vs. 8/31, 26% in control; 2 test, P Ͻ 0.01). ␣,␤-meATP (30 M) also produced a greater depolarization in TL c-DRG neurons from control mice compared with LS counterparts (TL: 15.7 Ϯ 2.0 mV; LS: 9.5 Ϯ 1.5 mV. Student's t-test, P Ͻ 0.05; Table 2 ). While the fraction of responsive cells increased, the depolarization produced by ␣,␤-meATP did not change after zymosan treatment in either TL or LS c-DRG neurons.
Whole cell Kv currents
Several currents may contribute to changes in neuron excitability (e.g., inward rectifying potassium currents, voltagesensitive sodium or calcium currents). Accordingly, we examined whether Kv channels also were involved in the zymosanproduced increase in membrane excitability of c-DRG neurons. Total whole cell Kv current density was not changed in either TL or LS c-DRG neurons after zymosan treatment, and neither was the sustained nor transient Kv component (Ϫ30 mV prepulse; Fig. 3 ).
Characterization of P2X receptor-mediated currents in c-DRG neurons
LS c-DRG NEURONS. To evaluate functionally purinergic receptors on c-DRG neurons, we applied ATP (100 M), which triggered total whole cell Kv current non-inactivated Kv current inactivated Kv current inward currents in most LS neurons tested (saline-treated, 39/57, 68%; zymosan-treated, 28/39, 72%). Based on the kinetics of current decay, we differentiated fast, slow, and sustained currents in neurons from saline-and zymosan-treated mice (Fig. 4) . In saline-treated mice, 14/39 (36%), 16/39 (41%), and 9/39 (23%) LS c-DRG neurons expressed fast, slow, and sustained current kinetics, respectively. Similar proportions of LS c-DRG neurons from zymosan-treated mice, 9/28 (32%), 9/28 (32%), and 8/28 (32%) expressed fast, slow, and sustained current kinetics, respectively. The 10 -80% rise time and desensitizing time constants of fast and slow current kinetics generated by ATP did not differ between saline-and zymosan-treated mice in LS c-DRG neurons (Table 3) . We also examined the effects of ␣,␤-meATP (100 M), which produced inward currents in LS c-DRG neurons (salinetreated, 26/51, 51%; zymosan-treated, 33/63, 52%) (Fig. 5) . Based on the current kinetics described in the preceding text, we identified fast (9/26, 36%) and slow (17/26, 65%) currents in LS c-DRG neurons from saline-treated mice and similar proportions of fast (15/33, 45%) and slow (18/33, 55%) currents in LS c-DRG neurons from zymosan-treated mice. The activation and desensitization kinetics were similar to those obtained in response to ATP and did not differ between neurons from saline-and zymosan-treated mice (Table 3) . TL c-DRG NEURONS. Similar to LS neurons, ATP (100 M) produced inward currents in most TL c-DRG neurons tested (saline-treated, 27/37, 73%; zymosan-treated, 41/57, 72%). In saline-treated mice, 18/27 (67%), 7/27 (26%), and 2/27 (7%) TL c-DRG neurons expressed fast, slow, and sustained current kinetics, respectively. The relative proportion of these kinetic properties did not differ in neurons from zymosan-treated mice [fast (31/41, 76%), slow (8/41, 20%), and sustained (2/41, 5%) currents; Fig. 4 ]. Similar to LS c-DRG neurons, the 10 -80% rise time and desensitizing time constants of fast and slow current kinetics generated by ATP did not differ between saline-and zymosan-treated mice in TL neurons (Table 3) .
A high proportion of TL c-DRG neurons tested (saline-treated, 38/46, 82%; zymosan-treated, 48/60, 80%) responded to ␣,␤-meATP (Fig. 5) . Like ATP, ␣,␤-meATP triggered similar proportions of fast and slow currents in TL neurons from salinetreated (fast, 31/38, 82%; slow, 7/38, 18%) and zymosan-treated (fast, 37/48, 77%; slow, 11/48, 23%) mice. As described for LS c-DRG neurons, the activation and desensitization kinetics were similar to those obtained in response to ATP, 10 -80% rise time, and desensitizing time of fast and slow current kinetics generated by ␣,␤-meATP did not differ between saline-and zymosantreated mice in TL neurons (Table 3) .
Effects of P2X 3 deletion and purinergic antagonists on P2X-dependent currents
To establish that the fast current triggered by ATP and ␣,␤-meATP is dependent on P2X 3 receptors, we examined c-DRG neurons from P2X 3 Ϫ/Ϫ mice. The genetic status of the mice was established by polymerase chain reaction for the P2X 3 gene. In LS and TL c-DRG neurons from P2X 3 Ϫ/Ϫ mice, a transient current was not produced either by ATP or ␣,␤-meATP (Fig. 6) . However, we did observe a sustained current in response to ATP in 1/5 neurons (3 mice were used for harvesting cells; 1 cell from 1 mouse, 2 cells each from 2 mice). To further examine P2X-dependent currents, we applied the potent and selective homomeric P2X 3 and heteromeric P2X 2/3 receptor antagonist A-317491 (Jarvis et al. 2002) to c-DRG neurons from saline-treated mice. In the presence of A-317491 (10 M), both ATP-and ␣,␤-meATP-mediated fast and slow currents were reversibly attenuated (Fig. 7) .
P2X receptor dose-response relationship
We next determined the dose-response relationship for both agonists by applying either ATP or ␣,␤-meATP in increasing concentrations. In TL and LS c-DRG neurons, both ATP-and ␣,␤-meATP-activated currents were concentration-dependent for both fast and slow currents (Figs. 8 and 9 ). The doseresponse curves of fast but not slow currents induced by ␣,␤-meATP shifted to the left in c-DRG neurons from zymosan-treated mice. The logEC 50 for ␣,␤-meATP to induce the fast current in LS c-DRG neurons from zymosan-treated mice (Ϫ5.30 Ϯ 0.19) showed a tendency toward a decrease compared with that from saline-treated mice (Ϫ4.65 Ϯ 0.45; Student's t-test, P ϭ 0.18). When analyzed using two way ANOVA followed by the Holm-Sidak multiple comparison test, a significant increase in the fast current density was detected at 30 M ␣,␤-meATP in LS c-DRG neurons from zymosan-treated mice (P Ͻ 0.05). For fast currents in TL c-DRG neurons, logEC 50 values for ␣,␤-meATP (zymosantreated; Ϫ5.37 Ϯ 0.09. saline-treated; Ϫ4.65 Ϯ 0.30. Student's t-test, P Ͻ 0.05) were significantly lower after zymosan treatment compared with saline treatment, and the current density at 10 M ␣,␤-meATP was significantly increased in TL c-DRG neurons from zymosan-treated mice (P Ͻ 0.05, 2 way ANOVA followed by the Holm-Sidak multiple comparison test). Ϫ/Ϫ mice; a sustained current, however, was present.
P2X immunohistochemistry and mRNA expression in c-DRG neurons
DiI-positive c-DRG neurons co-labeled for P2X 3 were present in both TL and LS DRG (Fig. 10) . There was no significant difference in P2X 3 immunoreactivity between LS (47/320; 15%) and TL (33/170; 19%) c-DRG neurons and zymosan treatment did not alter these proportions (LS: 52/286, 18%; TL: 39/155; 25%).
To evaluate expression of P2X 2 and P2X 3 in LS and TL c-DRG neurons, we performed single-cell RT-PCR on DiIlabeled c-DRG neurons (Table 1A) . Table 1B shows the percentage of c-DRG neurons expressing only P2X 3 , only P2X 2 and both P2X 3 and P2X 2 transcripts. Transcripts for P2X 2 and/or P2X 3 were present in nearly all colon neurons examined with about half of the cells only containing P2X 3 transcripts. While purinergic agonist triggered fast currents more frequently in TL than LS c-DRG neurons, the percentage of cells only expressing P2X 3 did not differ between these two populations under control conditions and was not changed by zymosan treatment.
D I S C U S S I O N
These findings add to a growing literature demonstrating the importance of peripheral sensitization and P2X receptors in visceral hypersensitivity. The novel aspect of the present report relates to the IBS-like colorectal insult produced by intracolonic instillation of zymosan, which is characterized by longlasting colorectal hypersensitivity in the absence of colorectal inflammation assessed either by neutrophilic infiltration (myeloperoxidase assay) or histologically Shinoda et al. 2009 ). Significantly, spontaneous action potential discharges of c-DRG neurons were increased as has been reported after significant insult and inflammation of visceral organs (Bielefeldt et al. 2002; Dang et al. 2004 Dang et al. , 2005b Yoshimura and De Groat. 1999) . This enhanced excitability has been attributed to decreased transient outward potassium currents (Dang et al. 2004; Ibeakanma et al. 2009 ) and increases in voltage-gated sodium channel 1.8 protein expression (King et al. 2009 ) and its current density (Beyak et al. 2004; Bielefeldt et al. 2002) , lowered input resistance, AP threshold (Moore et al. 2002) , and rheobase (Ibeakanma et al. 2009 ) in DRG neurons innervating visceral organs.
In the present study, consistent with the absence of significant colonic insult, we did not see changes in neuron size or potassium currents that have previously been described in animal models of visceral hypersensitivity associated with inflammation (Dang et al. 2004; Yoshimura and De Groat. 1999) . We found that zymosan had no effect on voltage-gated K ϩ currents, suggesting that voltage-gated K ϩ currents do not play a role in the mechanism(s) underlying zymosan-produced neuron excitability. Because of the present focus on purinergic receptors, we did not specifically investigate other currents that may contribute to changes in excitability, such as inward rectifying potassium currents or voltage-sensitive sodium or * * . Concentration-response relationship for ␣,␤-meATP. Current responses were generated for kinetically distinct currents. In TL c-DRG neurons, zymosan treatment significantly lowered the EC 50 and increased the peak current of the fast component induced by 10 M ␣,␤-meATP. *P Ͻ 0.05.
Antagonism of purinergic-activated fast and slow inward currents by co-application of the P2X 3, 2/3 receptor antagonist, A-317491. calcium currents. Zymosan treatment significantly increased the number of TL c-DRG neurons firing APs in response to ATP application. Because ATP-induced depolarization was not significantly changed by zymosan, the increase is likely the result of a decrease in RMP rather than a change in ATP current responses.
Recent studies have documented the importance of purinergic signaling in visceral sensory physiology. Colon distension increases ATP release into the colon lumen, which is further increased after induction of experimental colitis (Wynn et al. 2004) . P2X 3 Ϫ/Ϫ mice have blunted basal responses to colorectal distension and do not develop hypersensitivity after zymosan treatment (Shinoda et al. 2009 ). The data presented here suggest that enhanced purinergic signaling contributes to the hypersensitivity, which has not previously been studied in c-DRG neurons.
Purinergic currents in c-DRG neurons
Using teased fiber recordings, we previously demonstrated significant differences between LS and TL colon sensory pathways (Brierley et al. 2004) . Consistent with anatomic and functionally distinct roles, we document here differences in responses to purinergic agonists; most TL c-DRG neurons exhibited fast currents, whereas LS c-DRG neurons had similar proportions of fast and slow purinergic responses. The P2X purinergic identity of the currents was further confirmed by the absence of the fast current in c-DRG neurons from P2X 3 Ϫ/Ϫ mice and also by reversible inhibition of ATP-and ␣,␤-meATPmediated fast and slow currents by the P2X 3 -P2X 2/3 antagonist A-317491. This suggests that the slow current is primarily due to activation of heteromeric P2X 2/3 receptors, whereas the fast current is mediated by homomeric P2X 3 receptors.
The single-cell PCR results for P2X 3 and P2X 2 transcripts revealed a greater frequency of expression in c-DRG neurons than percentages of neurons giving fast and slow responses to purinergic agonists, not surprisingly revealing greater sensitivity of the former. DiI-positive c-DRG neurons co-labeled for P2X 3 were present in both TL and LS DRG. The proportions of co-labeled c-DRG neurons were less than reported by others (Brierley et al. 2005; Robinson et al. 2004 ). The discrepancy may be due to use of a different retrograde tracer (e.g., fast blue) or, more likely, due to the limited number of DiI injections made into the colon wall in the present experiments. In contrast, immunohisto-chemical evaluation of P2X 3 in c-DRG neurons revealed less sensitivity than the functional whole cell results. The present electrophysiological results (purinergic responses in about 2/3 of the cells) are in line with prior publications (Chen and Gebhart. 2009; Dang et al. 2005a ) suggesting that differences in the sensitivities of RNA-based or immunohistochemical assays are responsible for these discrepancies. Number of data points for a does-response curve construction are in parentheses. 
Purinergic responses and colorectal hypersensitivity
We noted a significant shift in the concentration-response relationship for the fast purinergic current; this may suggest a potential mechanism to explain why P2X 3 Ϫ/Ϫ mice do not develop zymosan-induced colon hypersensitivity (Shinoda et al. 2009 ). Although we did not detect any changes in kinetic properties of ATP (100 M)-and ␣,␤-meATP (100 M)-evoked currents in TL or LS c-DRG neurons or the proportions or current density of P2X 3 -like fast current and slow P2X 2/3 -like currents after zymosan treatment, the EC 50 for the ␣,␤-meATP-produced fast current in TL c-DRG neurons was significantly lower. These findings differ from those produced by frank organ inflammation (e.g., cystitis) (Dang et al. 2008 ), which affect current kinetics and the relative contribution of fast and slow purinergic currents. Importantly, changes in excitability and purinergic responses were seen in TL and LS neurons innervating the colon, suggesting that both pelvic and splanchnic pathways participate in visceral hypersensitivity.
Although the mechanism(s) for the leftward shift of P2X 3 -agonists concentration-response curves in c-DRG neurons after zymosan treatment is unclear, it is noteworthy that P2X 3 function can be upregulated by calcitonin gene-related peptide (CGRP) and nerve growth factor (NGF), both of which are known to participate in visceral pain in IBS models (Barreau et al. 2008; Bourdu et al. 2005) . CGRP stimulates trafficking of P2X 3 receptors from intracellular stores to the cell membrane via protein-kinase-A-and protein-kinase-C-dependent mechanisms (Fabbretti et al. 2006) , and NGF rescues P2X 3 from an inhibitory control of conductance by C-terminal Src inhibitory kinase-dependent phosphorylation (D'Arco et al. 2009 ). It would be of interest to study whether these mechanisms underlie the increased P2X 3 -mediated responses in c-DRG neurons after zymosan treatment.
In summary, mild colonic insult enhanced membrane excitability and shifted the dose-response relationship to P2X 3 agonists in TL c-DRG neurons, thereby contributing to the development of colon hypersensitivity. Responses to purinergic agonists differed between TL and LS c-DRG neurons, providing further evidence that these afferent pathways are indeed physiologically distinct. The properties of both TL and LS c-DRG neurons changed after zymosan treatment, arguing against a selective role of splanchnic pathways in the development of hypersensitivity during and after visceral insult. While we cannot exclude contribution of central P2X 3 receptors as previously reported (Shinoda et al. 2009 ), the present results suggest that purinergic signaling contributes to peripheral sensitization. (Table 4) 
